© Copyright GW Pharmaceuticals 2021
This website is intended for healthcare professionals only. If you are not a healthcare professional, please visit www.gwpharm.co.uk
Date of Preparation: April 2021
Enjoying Epilepsy Focus? Want to expand your knowledge on cannabinoid science, the GW CBD manufacturing process, and the latest LGS, DS and GW CBD clinical data?
We are delighted to announce the upcoming Epilepsy DiaLoGS Virtual meetings.
The objectives of these meetings are to:
- Discover the GW story and its leading position in cannabinoid science and medicines
- Provide up-to-date information on LGS, DS, cannabinoid science and GW CBD clinical data
- Share clinical experience and expert opinion on GW CBD
As a delegate you will attend highly interactive expert-led scientific sessions, virtual tours of GW's manufacturing facilities, case-based discussions and a panel discussion on the management of patients in the post-COVID-19 era with leading experts in Europe.
The next Epilepsy DiaLoGS Virtual meeting will be held on:
- Thursday 27 May 2021 (13:00–15:45 BST; 14:00–16:45 CEST)
There are also more meetings planned the rest of the year (hopefully face to face)!
To register your interest in attending these exciting meetings or to request further information, please contact Mr Fin Curson using the following email:
Presentation and Q&A
|Growing and manufacturing virtual overview/tours
Virtual tour and Q&A
|Management of developmental and epileptic encephalopathies
Presentation, clinical case and Q&A
|GW CBD shared experience
Clinical cases and group discussion
All-faculty panel discussion
|Summary and meeting close|
This event is organised and sponsored by GW Pharmaceuticals.